Business Segments · Revenue
Pharmaceutical and Specialty Solutions — Revenue
Cardinal Health Pharmaceutical and Specialty Solutions — Revenue decreased by 7.5% to $56.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $50.43B to $56.11B. Over 2 years (FY 2022 to FY 2025), Pharmaceutical and Specialty Solutions — Revenue shows an upward trend with a 11.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ3 2021
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
Growth indicates increased market share, higher demand, or successful price realization.
Detailed definition
The total gross sales generated from the distribution of branded, generic, and specialty pharmaceutical products to heal...
Peer comparison
Standard primary revenue metric for all major pharmaceutical wholesalers.
Metric ID:
cah_segment_pharmaceutical_and_specialty_solutions_revenueHistorical Data
16 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.15B | $41.15B | $41.15B | $41.15B | $46.50B | $50.59B | $53.20B | $50.65B | $55.58B | $47.99B | $50.85B | $50.43B | $55.37B | $59.21B | $60.67B | $56.11B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +13.0% | +8.8% | +5.2% | -4.8% | +9.7% | -13.7% | +6.0% | -0.8% | +9.8% | +6.9% | +2.5% | -7.5% |
| YoY Change | — | — | — | — | +13.0% | — | — | +8.9% | — | -5.1% | -4.4% | -0.4% | -0.4% | +23.4% | +19.3% | +11.3% |
Range$41.15B – $60.67B
CAGR+8.6%
Avg YoY Growth+7.3%
Median YoY Growth+8.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical and specialty solutions — revenue?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — revenue of $56.11B in Q1 2026.
- How has Cardinal Health's pharmaceutical and specialty solutions — revenue changed year-over-year?
- Cardinal Health's pharmaceutical and specialty solutions — revenue increased by 11.3% year-over-year, from $50.43B to $56.11B.
- What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — revenue?
- Over 2 years (2022 to 2025), Cardinal Health's pharmaceutical and specialty solutions — revenue has grown at a 11.5% compound annual growth rate (CAGR), from $164.60B to $204.64B.
- What does pharmaceutical and specialty solutions — revenue mean?
- Total sales revenue generated by the pharmaceutical and specialty solutions business segment.